UPDATE 1-Aeterna shares halve after FDA rejects growth hormone test

Nov 6 (Reuters) - Aeterna Zentaris Inc said the U.S. Food and Drug Administration rejected macimorelin, which the company had hoped would be the first orally administered drug to determine if adults...

from Reuters: Hot Stocks http://ift.tt/1uABjfx